Among all the compounds with inhibitory activity on both HDAC1 and two breast cancer cell lines, compound ZN444B displays the highest anti-proliferative activity, therefore, ZN444B was chosen for further biological evaluation. Here, HDAC1 is linked to breast carcinoma.